Deficiency of electroneutral K+-Cl- cotransporter 3 causes a disruption in impulse propagation along peripheral nerves.
Nerve conduction requires the fine tuning of ionic currents through delicate interactions between axons and Schwann cells. The K(+)-Cl(-) cotransporter (KCC) family includes four isoforms (KCC1-4) that play an important role in the maintenance of cellular osmotic homeostasis via the coupled electroneutral movement of K(+) and Cl(-) with concurrent water flux. Mutation in SLC12A6 gene encoding KCC3 results in an autosomal recessive disease, known as agenesis of the corpus callosum associated with peripheral neuropathy. Nevertheless, the role of KCC3 in nerve function remains a puzzle. In this study, the microscopic examination of KCC isoforms expressed in peripheral nerves showed high expression of KCC2-4 in nodal segments of the axons and in the perinucleus and microvilli of Schwann cells. The KCC inhibitor [[(dihydroindenyl)oxy]alkanoic acid] but not the Na(+)-K(+)-2Cl(-)-cotransport inhibitor (bumetanide) dose-dependently suppressed the amplitude and area of compound muscle action potential, indicating the involvement of KCC activity in peripheral nerve conduction. Furthermore, the amplitude and area under the curve were smaller, and the nerve conduction velocity was slower in nerves from KCC3(-/-) mice than in nerves from wild-type mice, while the expression pattern of KCC2 and KCC4 was similar in KCC3 kockout and wild-type strains. KCC3(-/-) mice also manifested a prominent motor deficit in the beam-walking test. This is the first study to demonstrate that the K(+)-Cl(-) cotransporter activity of KCC3 contributes to the propagation of action potentials along peripheral nerves.
Sun
Yuan-Ting
YT
Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Lin
Thy-Sheng
TS
Tzeng
Shun-Fen
SF
Delpire
Eric
E
Shen
Meng-Ru
MR
D000085:Acetates / Q000494:pharmacology; D000200:Action Potentials / Q000235:genetics; D000818:Animals; D001369:Axons / Q000378:metabolism / Q000473:pathology; D015820:Cadherins / Q000235:genetics / Q000378:metabolism; D004558:Electric Stimulation / Q000379:methods; D066298:In Vitro Techniques; D007192:Indenes / Q000494:pharmacology; D051663:Kv1.2 Potassium Channel / Q000378:metabolism; D008124:Locomotion / Q000235:genetics; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009431:Neural Conduction / Q000187:drug effects / Q000235:genetics* / Q000502:physiology; D011901:Ranvier's Nodes / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D011930:Reaction Time / Q000187:drug effects / Q000235:genetics; D012583:Schwann Cells / Q000378:metabolism; D020426:Sciatic Neuropathy / Q000235:genetics* / Q000473:pathology / Q000503:physiopathology*; D027981:Symporters / Q000037:antagonists & inhibitors / Q000172:deficiency* / Q000378:metabolism; D000096922:K Cl- Cotransporters
D000085:Acetates; D015820:Cadherins; D007192:Indenes; D051663:Kv1.2 Potassium Channel; D027981:Symporters; C492280:Slc12a6 protein, mouse; D000096922:K Cl- Cotransporters; C095651:((2-n-butyl-6,7-dichloro-2-cyclopentyl-2,3-dihydro-1-oxo-1H-inden-5-yl)oxy)acetic acid